Zobrazeno 1 - 10
of 60
pro vyhledávání: '"R. J. van Klaveren"'
Autor:
Suzie J. Otto, C. A. van Iersel, C.M. van der Aalst, R. J. van Klaveren, F. J. M. Frenken, Matthijs Oudkerk, Jacques Fracheboud, H.J. de Koning, P. A. de Jong
Publikováno v:
Lung Cancer, 77(1), 51-57. ELSEVIER IRELAND LTD
Lung Cancer, 77(1), 51-57. Elsevier Ireland Ltd
Lung Cancer, 77(1), 51-57. Elsevier Ireland Ltd
The degree of self-selection in the Dutch-Belgian randomised controlled lung cancer screening trial (NELSON) was determined to assess the generalisability of the study results. 335,441 (mainly) men born in 1928-1953 received a questionnaire. Of the r
Autor:
K. A. M. van den Bergh, Gerard J. J. M. Borsboom, Marie-Louise Essink-Bot, R. J. van Klaveren, H.J. de Koning, E. Th Scholten, Mathias Prokop
Publikováno v:
British Journal of Cancer, 102, 1, pp. 27-34
British Journal of Cancer, 102(1), 27-34. Nature Publishing Group
British Journal of Cancer, 102, 27-34
British Journal of Cancer
British journal of cancer, 102(1), 27-34. Nature Publishing Group
British Journal of Cancer, 102(1), 27-34. Nature Publishing Group
British Journal of Cancer, 102, 27-34
British Journal of Cancer
British journal of cancer, 102(1), 27-34. Nature Publishing Group
BACKGROUND: In lung cancer CT screening, participants often have an indeterminate screening result at baseline requiring a follow-up CT. In subjects with either an indeterminate or a negative result after screening, we investigated whether health-rel
Autor:
Joachim G.J.V. Aerts, René M. Vernhout, Henk C. Hoogsteden, J Gras, E. Pouw, K. Y. Tan, V. Surmont, P.I.M Schmitz, T Pronk, R. J. van Klaveren, J Salome
Publikováno v:
Lung Cancer, 66(3), 333-337. Elsevier Ireland Ltd
Background: Oral treatment regimens with few side effects are appealing in the 2nd or 3rd line treatment of non-small cell lung cancer (NSCLC) patients. Purpose: The aim was to investigate the efficacy and toxicity of the oral combination etoposide,
Autor:
Hester A. Gietema, R. J. van Klaveren, J. M. M. Van Den Bosch, Pieter Zanen, Jan Willem J. Lammers, I. van der Lee, Mathias Prokop
Publikováno v:
Respiratory Medicine, 103(12), 1892-1897. W.B. Saunders
Respiratory Medicine, 103, 1892-7
Respiratory Medicine, 103, 12, pp. 1892-7
Respiratory Medicine, 103, 1892-7
Respiratory Medicine, 103, 12, pp. 1892-7
The diffusion capacity for nitric oxide (DLNO) is independent of Pulmonary capillary blood volume and equals the membrane diffusing capacity. Therefore the DLNO could be more sensitive in detecting alveolar destruction than the DLCO. We measured flow
Publikováno v:
European Respiratory Journal, 33(5), 1206-1215. European Respiratory Society
Complete anatomical resection of the primary tumour is still the standard of care in patients with early stage lung cancer. Because these patients are usually smokers who also suffer from chronic obstructive pulmonary disease, regional differences in
Autor:
Mathias Prokop, H.J. de Koning, de Truuske Bock, Hester A. Gietema, Anne Leusveld, Johny Verschakelen, R. J. van Klaveren, Ying Wang, Matthijs Oudkerk, Ernst Th. Scholten, H. J. van der Zaag-Loonen, Dong Ming Xu
Publikováno v:
Radiology, 248(2), 625-631. Radiological Society of North America Inc.
Radiology, 248(2), 625-631. RADIOLOGICAL SOC NORTH AMERICA
Radiology, 248(2), 625-631. RADIOLOGICAL SOC NORTH AMERICA
Purpose: To retrospectively assess volume measurement variability in solid pulmonary nodules (volume, 15-500 mm(3)) detected at lung cancer screening and to quantify the independent effects of nodule morphology, size, and location.Materials and Metho
Autor:
Catherine Legrand, P. Van Schil, Franz M.N.H. Schramel, V. Surmont, Christian Manegold, R. J. van Klaveren, C. Goor, J. Van Meerbeeck
Publikováno v:
Lung cancer: journal of the International Association for the Study of Lung Cancer
The present EORTC phase II feasibility study in stage IIIB (T4-N3) NSCLC was conducted to investigate whether an induction regimen with concurrent chemoradiotherapy followed by surgery after restaging by re-mediastinoscopy and/or fluorodeoxyglucose-
Autor:
Henk C. Hoogsteden, R. J. van Klaveren, V. Surmont, René M. Vernhout, K. Y. Tan, Suresh Senan, G. van Wijhe, Joachim G.J.V. Aerts, J. Van Meerbeeck, G.T. Verhoeven
Publikováno v:
Journal of Thoracic Oncology, 1(6), 532-536. International Association for the Study of Lung Cancer
Aerts, J G J V, Surmont, V, Van Klaveren, R J, Tan, K Y, Senan, S, Van Wijhe, G, Vernhout, R, Verhoeven, G T, Hoogsteden, H C & Van Meerbeeck, J P 2006, ' A phase II study of induction therapy with carboplatin and gemcitabine among patients with locally advanced non-small cell lung cancer ', Journal of Thoracic Oncology, vol. 1, no. 6, pp. 532-536 . https://doi.org/10.1097/01243894-200607000-00006
Aerts, J G J V, Surmont, V, Van Klaveren, R J, Tan, K Y, Senan, S, Van Wijhe, G, Vernhout, R, Verhoeven, G T, Hoogsteden, H C & Van Meerbeeck, J P 2006, ' A phase II study of induction therapy with carboplatin and gemcitabine among patients with locally advanced non-small cell lung cancer ', Journal of Thoracic Oncology, vol. 1, no. 6, pp. 532-536 . https://doi.org/10.1097/01243894-200607000-00006
INTRODUCTION: The objectives of this trial were to evaluate the activity and safety of gemcitabine carboplatin as induction therapy in patients with locally advanced non-small cell lung cancer METHODS: Patients received two cycles of gemcitabine (125
Autor:
Joost J. Nuyttens, Mischa S. Hoogeman, J.-B. Prévost, R. J. van Klaveren, J. Praag, Peter M. T. Pattynama, Peter C. Levendag
Publikováno v:
Acta Oncologica, 45(7), 961-965. Informa Healthcare
Lung tumor tracking during stereotactic radiotherapy with the CyberKnife requires the insertion of markers in or close to the tumor. To reduce the risk of pneumothorax, three methods of marker placement were used: 1) intravascular coil placement, 2)
Publikováno v:
Pulmonary Pharmacology & Therapeutics. 11:23-30
The aims of this study were to investigate the effect of hyperoxia on O 2 −· , H 2 O 2 and · NO generation and iNOS mRNA levels in rat type II pneumocytes in vitro and the possible protective effect of the lazaroid U-74389G. Rat type II pneumocyt